Wealthfront Advisers’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $31.9M | Buy |
90,562
+8,275
| +10% | +$2.95M | 0.07% | 104 |
|
|
2025
Q4 | $26.9M | Buy |
82,287
+12,054
| +17% | +$3.82M | 0.06% | 109 |
|
|
2025
Q3 | $19.8M | Buy |
70,233
+12,857
| +22% | +$3.73M | 0.05% | 126 |
|
|
2025
Q2 | $16M | Sell |
57,376
-8,689
| -13% | -$2.46M | 0.04% | 144 |
|
|
2025
Q1 | $20.6M | Buy |
66,065
+15,521
| +31% | +$4.58M | 0.06% | 106 |
|
|
2024
Q4 | $13.2M | Sell |
50,544
-2,565
| -5% | -$761K | 0.04% | 137 |
|
|
2024
Q3 | $17.1M | Sell |
53,109
-393
| -0.7% | -$129K | 0.05% | 105 |
|
|
2024
Q2 | $16.7M | Buy |
53,502
+2,883
| +6% | +$847K | 0.06% | 95 |
|
|
2024
Q1 | $14.4M | Sell |
50,619
-1,163
| -2% | -$340K | 0.05% | 108 |
|
|
2023
Q4 | $14.9M | Sell |
51,782
-1,170
| -2% | -$319K | 0.06% | 95 |
|
|
2023
Q3 | $14.2M | Sell |
52,952
-3,295
| -6% | -$822K | 0.06% | 90 |
|
|
2023
Q2 | $12.5M | Sell |
56,247
-8,060
| -13% | -$1.87M | 0.05% | 97 |
|
|
2023
Q1 | $15.5M | Sell |
64,307
-1,557
| -2% | -$382K | 0.07% | 75 |
|
|
2022
Q4 | $17.3M | Buy |
65,864
+8,993
| +16% | +$2.41M | 0.08% | 66 |
|
|
2022
Q3 | $12.8M | Buy |
56,871
+10,768
| +23% | +$2.61M | 0.07% | 75 |
|
|
2022
Q2 | $11.2M | Buy |
46,103
+13,473
| +41% | +$3.3M | 0.06% | 83 |
|
|
2022
Q1 | $7.89M | Buy |
32,630
+7,691
| +31% | +$1.77M | 0.03% | 135 |
|
|
2021
Q4 | $5.61M | Sell |
24,939
-4,079
| -14% | -$861K | 0.02% | 176 |
|
|
2021
Q3 | $6.17M | Sell |
29,018
-4,814
| -14% | -$1.11M | 0.03% | 130 |
|
|
2021
Q2 | $8.25M | Sell |
33,832
-850
| -2% | -$209K | 0.04% | 91 |
|
|
2021
Q1 | $8.63M | Buy |
34,682
+3,805
| +12% | +$908K | 0.05% | 76 |
|
|
2020
Q4 | $7.1M | Sell |
30,877
-2,395
| -7% | -$552K | 0.04% | 76 |
|
|
2020
Q3 | $8.46M | Sell |
33,272
-8
| -0% | -$1.98K | 0.06% | 62 |
|
|
2020
Q2 | $7.85M | Buy |
33,280
+2,147
| +7% | +$490K | 0.06% | 63 |
|
|
2020
Q1 | $6.31M | Buy |
31,133
+8,474
| +37% | +$1.85M | 0.06% | 59 |
|
|
2019
Q4 | $5.46M | Buy |
22,659
+1,637
| +8% | +$361K | 0.04% | 80 |
|
|
2019
Q3 | $4.07M | Buy |
21,022
+2,108
| +11% | +$405K | 0.03% | 85 |
|
|
2019
Q2 | $3.48M | Sell |
18,914
-1,334
| -7% | -$239K | 0.03% | 91 |
|
|
2019
Q1 | $3.85M | Sell |
20,248
-9,965
| -33% | -$1.9M | 0.04% | 85 |
|
|
2018
Q4 | $5.88M | Buy |
+30,213
| New | +$5.89M | 0.06% | 55 |
|
Other funds holding AMGN
VCM
VPM
Wealthfront Advisers's AMGN Position: Q1 2026 in Review
Wealthfront Advisers increased its Amgen (AMGN) stake by 10% in Q1 2026, buying an estimated $2.95M and bringing the position to 90,562 shares worth $31.9M. The position accounts for 0.07% of the portfolio, ranked #104.
Wealthfront Advisers first reported a position in AMGN in Q4 2018 and has held it in 30 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Wealthfront Advisers held 90,562 shares of Amgen worth $31.9M as of Q1 2026.
- Wealthfront Advisers bought 8,275 Amgen shares in Q1 2026, an estimated $2.95M.
- Amgen made up 0.07% of Wealthfront Advisers's portfolio in Q1 2026, its #104 holding.
- Wealthfront Advisers first reported a position in Amgen in Q4 2018 and has held it in 30 quarters since.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Wealthfront Advisers's 13F filing for Q1 2026, filed 5 May 2026.